IMC-Chicago »

Enliven Therapeutics shares owned by IMC-Chicago

Quarter-by-quarter ownership of Enliven Therapeutics shares owned by IMC-Chicago from 13F filings

Historical chart of IMC-Chicago investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by IMC-Chicago consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by IMC-Chicago

Quarter filed Position value Share count Share price at filing
2026-09-30 $243k 5.3k 45.84

Top funds holding Enliven Therapeutics